Please note that the Company does not update, correct or revise news releases after they have been issued. For the most current information about the Company, please refer to the most recent releases.

MEDIA ALERT: U.K. Eye Drop Recall

There have been a number of news reports regarding Bausch + Lomb’s recent voluntary recall of a single lot of proxymetacaine 0.5 percent Minims Eye Drops Solution in the United Kingdom. There have been no reports of any adverse events, and we are working closely with the MHRA on the matter. 

We take patient safety very seriously and initiated a voluntary recall of this single lot of product on December 10, 2012.

Importantly, this issue relates to a single lot of a prescription eye drop that is mainly used in hospitals in the United Kingdom.  This issue does not impact any other Bausch + Lomb products in any part of the world.

Customers who have additional questions should contact Bausch + Lomb Customer Services in Kingston, U.K. at: +44 208 781 2991.

About Bausch + Lomb

Bausch + Lomb is one of the best-known and most respected healthcare companies in the world. Its core businesses include contact lenses and lens care products, ophthalmic surgical devices and instruments, and ophthalmic pharmaceuticals. Founded in 1853, the company is headquartered in Rochester, N.Y., and employs roughly 11,000 people worldwide. Its products are available in more than 100 countries. More information is available at

Actions: E-mail | Permalink |